Infertility. Inability to achieve a pregnancy
Conditions
Interventions
Intervention 1: Intervention group:Patients receive 200 mg of coenzyme Q10 from 8 weeks before stimulates the egg agency to three months after . Intervention 2: Control group:Patients recieve placebo
Treatment - Drugs
Control group:Patients recieve placebo 8 weeks before stimulates the egg agency to three months after.
Intervention group:Patients receive 200 mg of coenzyme Q10 from 8 weeks before stimulates the egg agency to three months after .
Sponsors
Hamadan Univesity of Medical Sciences
Eligibility
Sex/Gender
Female
Age
35 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion caricteria:primary infertility; age over 35 years; FSH>10 on the third day of the cycle; ovarian volume<3ml; oocyte<3-5 Exclusion caricteria:Lack of consent to the continuation of the treatment;Not referring the patient to continue treatment at designated times; any current use of systemic steroid medication within 3 months of study enrollment; any contraindication to being pregnant and carrying a pregnancy to term; absence of one ovary; clinically relevant chronic systemic disease(diabet -HTN) and malagnancies; use of insuline ,beta blocker,TCA,Estatine,comadine,warfarine,phenazopridine
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pregnancy Rate. Timepoint: Every Cycle. Method of measurement: Pregnancy Test(BHCG). | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of days induction. Timepoint: Daily. Method of measurement: Counting the days.;Number of gonadotropin ampules induction. Timepoint: Daily. Method of measurement: Counting ampoules. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZhila Golmohammadi
Hamadan University of Medical Sciences
Outcome results
None listed